Inspire’s mission is to create life-saving gene therapies for individuals with devastating diseases of the lung. Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. Inspire is currently pursuing initiation of a First-in-Human clinical trial for a lethal neonatal lung dis...
Inspire’s mission is to create life-saving gene therapies for individuals with devastating diseases of the lung. Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. Inspire is currently pursuing initiation of a First-in-Human clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and other monogenic lung diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.